science wire

« BACK

Pharmacology



Results 1 - 50 of 3009.
1 2 3 4 5 ... 61 Next »


Health - Pharmacology - 20.09.2022
Experts create tool to help doctors avoid prescribing drugs to treat other drugs’ side effects
Medications are effective and powerful treatment options for protecting and advancing human health - but, if taken incorrectly, they can also cause harm, particularly among older adults who are taking multiple medications over long periods of time.

Health - Pharmacology - 06.09.2022
MedUni Vienna coordinating EU project to optimise the use of antirheumatic drugs
MedUni Vienna is coordinating an international research project to optimise the use of disease modifying antirheumatic drugs (DMARDs) for treating rheumatoid arthritis. The SQUEEZE project (Maximising Impact of Prescription Drugs in Rheumatoid Arthritis), with total funding of €10.2 million from the EU Framework Programme for Research and Innovation, includes 13 European consortium partners.

Health - Pharmacology - 01.09.2022
What you need to know about bivalent boosters for COVID-19
What you need to know about bivalent boosters for COVID-19
New booster shots designed to target the omicron variant and its subvariants, and the original strain of SARS-CoV-2, could become available in the U.S. in the coming weeks The SARS-CoV

Health - Pharmacology - 18.08.2022
First in Nation: UC San Diego Health Offers Treatment for Hereditary Amyloidosis
New medication allows for less frequent visits for patients, helping improve quality of life UC San Diego Health is first in the nation to offer a new injectable medication to patients with nerve dam

Health - Pharmacology - 01.08.2022
NHS must learn to love smart IV pumps to avoid drug errors
Hospitals must start using "smart" intravenous (IV) infusion technology to its full potential if they are to prevent dangerous drug errors, University of Manchester researchers have found.

Life Sciences - Pharmacology - 22.07.2022
Transport-proteins influence the lung uptake of inhaled drugs
A study by MedUni Vienna's Department of Clinical Pharmacology has identified two transport proteins that can influence the permeability of the lung epithelial barrier for certain drugs.

Health - Pharmacology - 05.07.2022
Pandemic Sciences Institute formally launched in Oxford
The University of Oxford's Pandemic Sciences Institute (PSI) has been formally launched at a two-day event at the Blavatnik School of Government, at which the lead researchers set out its direction and strategy for the next five years.

Health - Pharmacology - 30.06.2022
’Long COVID’ presents a major health challenge - how can Australia be prepared?
Triple vaccination seems to reduce the chance of long COVID - but we still need to prepare for a jump in cases, write researchers at the University of Sydney.

Pharmacology - Health - 30.06.2022
Documents show McKinsey’s role in fueling opioid crisis
New documents show McKinsey's role in fueling opioid epidemic Consulting firm's work with pharmaceutical companies to help increase sales detailed in UCSF-Johns Hopkins opioid documents archive The O

Health - Pharmacology - 29.06.2022
Q&A: What you should know about new COVID vaccines for young kids
Q&A: What you should know about new COVID vaccines for young kids
Vaccines against COVID-19 are finally available for the youngest Americans. The U.S. Food and Drug Administration voted on June 17 to authorize shots from Moderna and Pfizer for children as young as 6 months.

Health - Pharmacology - 29.06.2022
UCLA survey quantifies COVID-19 vaccine hesitancy among Californians
UCLA survey quantifies COVID-19 vaccine hesitancy among Californians
Despite the U.S. Food and Drug Administration's full approval of the COVID-19 vaccine, 58.8% of Californians who are not fully vaccinated are still worried about its side effects, according to a new UCLA survey.

Health - Pharmacology - 27.06.2022
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
Interrupting the treatment of vulnerable people on immune-suppressing medicines, doubles their antibody response to COVID-19 booster vaccination
A major clinical trial, led by experts at the University of Nottingham working in partnership with Universities and NHS hospitals including the University of Manchester , has found that by interrupting the treatment of vulnerable people on long-term immune suppressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.

Health - Pharmacology - 27.06.2022
MHH Sarcoma Center successfully DKG-certified
MHH Sarcoma Center successfully DKG-certified
Treatment of rare tumors: In addition to soft tissue tumors, the MHH is the only center in Lower Saxony to be certified for bone sarcomas.

Health - Pharmacology - 27.06.2022
The third wave of COVID-19 delivers the highest mortality risk in Australian ICUs
According to a new study led by Monash University, of those admitted to the ICU with COVID-19, after accounting for age and how sick patients were, the third wave of the disease in Australia was associated with the highest risk of dying in hospital, in comparison with earlier waves. Patients admitted to ICU during the third wave were mostly unvaccinated (75 per cent), younger than the previous two waves (24 per cent > 65 years of age), more likely to be pregnant and/or obese, and less likely to have co-morbid conditions.

Pharmacology - Health - 24.06.2022
Which patients with advanced prostate cancer will benefit from chemotherapy
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.

Health - Pharmacology - 23.06.2022
Researchers Continue Study of COVID-19 Vaccinations, Pregnancy and Postpartum
Ten-million-dollar grant over four years will support further examination of COVID-19 vaccination safety during pregnancy and immune response pre-and post-delivery With the SARS-CoV-2 pandemic ongoin

Pharmacology - Health - 23.06.2022
U.S. rolls out COVID-19 vaccines for youngest children
The CDC and FDA approved vaccines by Moderna and Pfizer/BioNTech in children older than 6 months; vaccinations began this week U.S. children older than 6 months are now eligible to rece

Health - Pharmacology - 22.06.2022
COPD patients respond equally well to COVID-19 vaccine
COPD patients respond equally well to COVID-19 vaccine
A study which tested the immune response of COPD patients to COVID-19 vaccination has shown they respond in a similar way to healthy people.

Health - Pharmacology - 22.06.2022
The path to personalised hepatitis D treatment
The path to personalised hepatitis D treatment
EU supports multicentre project with a total of 6.75 million euros Hepatitis D is by far the most severe form of chronic viral hepatitis, often leading to liver failure, liver cancer and death.

Health - Pharmacology - 21.06.2022
COVID-19 Rebound after Taking Paxlovid Likely Due to Insufficient Drug Exposure
Paxlovid rebound patient did not show drug resistance or impaired immunity; UC San Diego study suggests insufficient drug exposure was most likely cause Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals.

Pharmacology - Innovation - 20.06.2022
New spin-off QurieGen can have a major impact on drug development
QurieGen is a new spin-off of Radboud University that supports pharmaceutical companies in the early identification of successful drug molecules.

Health - Pharmacology - 17.06.2022
Heart surgery delays will cost lives, warns research
Pandemic has delayed lifesaving treatment for thousands of people with severe aortic stenosis. Our approach does not put the onus on only management or doctors, but creates a joint solution that is easier to implement in practice Feryal Erhun Urgent action is needed to clear the backlog of people with a common heart condition who are waiting for lifesaving treatment, according to published in the journal BMJ Open .

Health - Pharmacology - 17.06.2022
Kawasaki Disease Rates Dropped During COVID-19 Pandemic
UC San Diego researchers report significant decrease in national cases of Kawasaki disease in 2020; findings hint at origins of disease Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography and Rady Children's Hospital-San Diego teamed with partners across the United States to track rates of Kawasaki disease (KD) before and during the COVID-19 pandemic.

Health - Pharmacology - 16.06.2022
New system that defines Huntington’s Disease will ’revolutionise’ drug trials
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; paving the way for clinical trials of drugs in the earliest stages of HD.

Pharmacology - Health - 16.06.2022
Access to safer supply rapidly increased during COVID-19: study
Access to safer supply rapidly increased during COVID-19: study
Science, Health & Technology Kevin Hollett The number of programs and prescribers offering safer supply to reduce risk of overdose increased dramatically in the early days of the COVID-19 pandemic, according to a new study looking at services across Canada.

Health - Pharmacology - 16.06.2022
Peanut allergy treatment safest when started for infants under 12 months
Peanut allergy treatment safest when started for infants under 12 months
Science, Health & Technology Erik Rolfsen UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy. Now they have evidence that the earlier pre-schoolers start this treatment, the better. This real-world study focused on infants younger than 12 months old and reveals that not only is oral immunotherapy effective against peanut allergies, it's even safer for this age group than it is for toddlers and older pre-schoolers.

Health - Pharmacology - 16.06.2022
Researchers in Glasgow to receive £1.9m to tackle late stage cancer syndrome
Scientists at the Cancer Research UK Beatson Institute and the University of Glasgow are to receive £1.9m to explore the causes of a debilitating wasting disease that many people experience in the later stages of cancer. The funding is from Cancer Grand Challenges, a research initiative co-founded by Cancer Research UK and the National Cancer Institute in the US, which aims to encourage the world's leading researchers to tackle the toughest challenges faced by cancer patients.

Health - Pharmacology - 16.06.2022
FDA approves COVID-19 vaccines for children under 5 years old. What’s next?
Johns Hopkins vaccine expert Ruth Karron discusses the authorization of COVID-19 vaccines for those under 5 years old, and what's likely to happen with the authorization over the next few weeks The U

Pharmacology - Health - 16.06.2022
What you need to know about the Novavax vaccine
What you need to know about the Novavax vaccine
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19.

Pharmacology - Health - 15.06.2022
UK researchers pioneer new virtual treatment for PTSD
UK researchers pioneer new virtual treatment for PTSD
Researchers at Cardiff University have pioneered a new form of virtual treatment for people with post-traumatic stress disorder (PTSD).

Pharmacology - Health - 15.06.2022
$2.38M to test nano-engineered brain cancer treatment in mice
A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system A new nanomedicine that crosses the blood-brain barrier, engages the

Chemistry - Pharmacology - 14.06.2022
Mulliken Center of the University of Bonn and Merck cooperate in machine learning project
The Mulliken Center for Theoretical Chemistry at the University of Bonn is collaborating with Merck.

Health - Pharmacology - 14.06.2022
Bakar Fellows program names seven new Spark Award recipients
Anna Harte is the medical director of University Health Services at UC Berkeley.

Health - Pharmacology - 13.06.2022

Health - Pharmacology - 10.06.2022

Health - Pharmacology - 09.06.2022
Three UC3M COVID-19 research projects receive funding from the Community of Madrid
The Universidad Carlos III de Madrid (UC3M) has received 4,859,000 euros from the Community of Madrid to fund three COVID-19 research projects.

Pharmacology - Health - 09.06.2022
Concerns about new mutations as vaccine willingness slightly decreases
Concerns about new mutations as vaccine willingness slightly decreases
Two-thirds of the German population are concerned about new corona mutations; one-fifth of the population is very worried.

Health - Pharmacology - 09.06.2022
More than $19.7m awarded to Monash researchers for vital medical research
The National Health and Medical Research Council (NHMRC) has announced more than $19. M in funding for Monash research projects that incorporate diabetes, epilepsy and seizures, infection management, alcohol treatment, acidic blood trial and a new device to deliver treatment to premature babies.
1 2 3 4 5 ... 61 Next »